AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2024
Jan 26, 2024
33510_dirs_2024-01-26_6e344418-6d6d-469b-a8f2-a27993b45d32.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2024-01-24
Reporting Person: Williamson Robert F III (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-24 | Common Stock | P | 29862 | $0.49 | Acquired | 53542 | Direct |
| 2024-01-25 | Common Stock | P | 22134 | $0.49 | Acquired | 75676 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3663 | Indirect |
More from Perspective Therapeutics, Inc.
Report Publication Announcement
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Report Publication Announcement
2026
May 11
Report Publication Announcement
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16